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ABSTRACT 22 
Avian polyomavirus (APV) causes a range of disease syndromes in psittacine birds ranging from 23 
acute fatal disease to subclinical infections depending on age, species and a number of other 24 
unidentified factors. This study describes a survey of APV-specific antibodies in a captive 25 
population of 54 Spix’s macaws (Cyanopsitta spixii). A prevalence of 48.1% for APV-antibodies, 26 
indicating viral exposure, was found using a blocking enzyme-linked immunosorbent assay. Out 27 
of 36 Spix’s macaws that were serially tested over a period of four years, 50.0% were 28 
consistently positive, 36.1% were consistently negative, 5.5% had permanently declining 29 
antibody levels and 2.8% showed variable results. Using the PCR technique on whole blood, an 30 
apparent viraemia was detected in 2.3% of the birds, although contamination provides a likely 31 
explanation for this isolated positive PCR result in a hand-reared chick. A significantly higher 32 
white blood cell count was recorded in antibody-positive birds as compared to antibody-negative 33 
birds (p<0.05). As antibody-positive and antibody-negative birds were housed together without a 34 
change in their respective antibody status, transmission of APV within the adult breeding 35 
population appears to be a rare event. 36 
  37 
Key words: Spix’s macaws, Cyanopsitta spixii, avian polyoma virus, antibodies, blocking 38 
enzyme-linked immunosorbent assay 39 
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INTRODUCTION 41 
Avian polyomavirus (APV) was first described as the causative agent of budgerigar fledgling 42 
disease, an acute fatal disease of budgerigars (Melopsittacus undulatus) causing up to 100% 43 
mortality in neonates, and was subsequently designated as budgerigar fledgling disease virus 44 
(BFDV).1-4 Thereafter, APV has been detected repeatedly in other psittacine birds5-9 and 45 
sporadically in non-psittacine bird species.10-12  46 
In non-budgerigar psittacine species, APV infection of hand-reared nestlings can lead to 47 
either sudden death without any premonitory signs, or to acute fatal disease characterized by a 48 
brief period of lassitude, anorexia, delayed crop emptying and extensive subcutaneous, epicardial 49 
and serosal haemorrhages prior to death.5,6 Among parrots; macaws, conures, Eclectus parrots 50 
(Eclectus roratus) and lovebirds display a particular susceptibility to APV disease.13,14 51 
Conversely, infection of parent-raised chicks and adult birds - in most cases - is not synonymous 52 
with disease.11,13,15 It has been suggested that asymptomatic, juvenile and young adult 53 
budgerigars are responsible for transmission of virus through droppings, skin and feather dander 54 
to neonatal birds - which are at a substantially higher risk of fatal disease.14-17 In case of non-55 
budgerigar psittacines, however, the lack of consistent epidemiological data and the variation 56 
observed between species precludes a definite conclusion regarding persistence of antibody titres, 57 
duration of viraemia and virus shedding in natural APV infections. 8,9,18-21  58 
APV is a polyomavirus known to be highly stable in the environment.2,3,22,23 All APV strains 59 
characterized so far belong to one genotype and one serotype.10,24-26 Diagnosis of APV infection 60 
in live birds can be done by a polymerase chain reaction (PCR) on blood, feathers and cloacal 61 
swabs.8,10,27 Additionally, detection of APV-specific antibodies can be performed using either a 62 
serum neutralisation test (SNT) or a blocking enzyme-linked immunosorbent assay (BELISA); 63 
the results of both tests have been shown to correlate well with each other.9,17,24,28 64 
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The Spix’s macaw (Cyanopsitta spixii; Psittaciformes, Aves) is often considered to be the 65 
most threatened parrot in the world and duly classified as “Critically Endangered (possibly 66 
extinct in the wild)” after the last known male disappeared from its native habitat in late 2000.29,30 67 
Out of a captive population of 78 Spix’s macaws, which are part of an international recovery 68 
effort, 50 birds, representing almost 65% of the extant population, are kept at Al Wabra Wildlife 69 
Preservation (AWWP), Qatar. In total, AWWP has been home to 62 birds up until 2007.  70 
 71 
MATERIALS AND METHODS 72 
The 54 Spix’s macaws in this study included 23 males and 31 females. Most of the birds had 73 
been acquired by AWWP from captive populations in the Philippines and Switzerland between 74 
2000 and 2004. Unfortunately, no reliable health or management records existed for these birds 75 
prior to their transfer to AWWP. Between 2004 and 2007, 16 chicks hatched at AWWP and all 76 
chicks were hand-reared and housed in isolation from the adult birds. The Spix’s macaws at 77 
AWWP are maintained in aviary complexes separate from the other avian species kept at the 78 
facility. 79 
The age of the birds tested ranged from 1 to 22 years. All birds were housed in aviaries with 80 
inside air-conditioned rooms and outdoor flights with artificial rainfall systems. They were 81 
usually kept either individually or in pairs, except in some cases where juveniles were flocked. 82 
The birds had been subjected to annual health checks since 2004, during which they were tested 83 
for APV among other pathogens. AWWP had no history of APV vaccination, clinical APV 84 
infection, or evidence of APV-associated mortality in the Spix’s macaw population. 85 
Approximately 2.5 ml of blood was collected by jugular venipuncture from each bird under 86 
isoflurane anaesthesia and stored in lithium-heparin micro tubes. A fresh thin blood smear was 87 
prepared immediately from each bird using the slide to slide method. Plasma was always 88 
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separated within 4 hours of collection and frozen (-20°C) until dispatch to the laboratory for 89 
detection of APV antibodies. For detection of APV DNA, approximately 0.2 ml of blood was 90 
also stored immediately after collection in micro tubes of 1.3 ml capacity containing potassium 91 
EDTA and frozen (-20°C) until dispatch to the laboratory. Feather samples for APV DNA 92 
analysis were stored in re-sealable plastic bags. 93 
The presence of APV-specific antibodies was tested using a blocking enzyme-linked 94 
immunosorbent assay (BELISA).24 The test employs a monoclonal antibody directed against the 95 
major structural protein VP1 of APV in an ELISA format with purified APV particles as antigen. 96 
It measures the inhibition of color reaction of a test serum as compared to a defined negative 97 
control serum. According to results of SNT, more than 50% inhibition is considered positive, 98 
whereas less than 50% inhibition is considered negative.24 The BELISA was validated for a 99 
number of psittacine species.24,31 36 Spix’s macaw individuals were re-sampled in subsequent 100 
years. Testing interval for an individual ranged from 1 month to 28 months with a median of 10 101 
months between consecutive tests.  102 
Testing for the presence of the APV genome in blood or feathers was performed by PCR. 103 
The DNA was isolated from blood samples using the DNeasy Tissue Kit® (Qiagen GmbH, 104 
40724 Hilden, Germany) as recommended by the supplier. For DNA preparation from feather 105 
samples, a proteinase K digestion followed by phenol/chloroform/isoamylalcohol extraction and 106 
ethanol precipitation was performed as described previously.32 PCR analysis was done by 107 
amplification of a 310 bp fragment of the APV genome, as described previously,33-35 but by 108 
addition of SYBR Green I dye (Invitrogen BV, 9351 NV Leek, The Netherlands) and PCR 109 
product melting curve analysis in a Rotorgene 2000 Thermal Cycler® (Corbett Research 110 
Australia, Mortlake, NSW 2137, Australia). Precautions were taken to prevent laboratory 111 
contaminations and all reactions were controlled by the use of negative DNA isolation controls 112 
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as well as negative PCR reaction controls. PCR reactions were first analysed by melting curve 113 
analysis, and samples showing a melting peak between 80°C and 85°C were further analysed by 114 
electrophoresis on ethidium bromide-stained 2% agarose gels. PCR products with a length of 310 115 
bp were considered positive.  116 
Fresh thin blood smears stained with Diff-Quick® stain (Medion Diagnostics AG, 3186 117 
Duedingen, Switzerland) were evaluated for Total White Blood Cell counts (WBC) and 118 
Differential Leukocyte Count following the methods described previously.36 Plasma 119 
biochemistry and enzymes were processed on a dry automated analyzer (Spotchem EZ SP-4430, 120 
A. Menarini Diagnostics, 41460 Neuss, Germany).  121 
The haematological and biochemical data from 2004 to 2006 were evaluated separately for 122 
juveniles (birds less than 4 years; n=16 testing occasions) and adults (n=89 testing occasions). 123 
Only decreased or increased parameters, as compared to reference ranges recently established for 124 
the species,36 were examined. Differences between birds with positive and negative APV titres 125 
were assessed by t-test for parameters with normal distribution. As the percentage of monocytes 126 
was not normally distributed, differences in this parameter were tested by U-test. Statistical 127 
analyses were performed using the statistical package SPSS 14.0 (SPSS Inc., Chicago, IL 60606-128 
6307, USA), with p < 0.05 as significance threshold. 129 
 130 
RESULTS 131 
All birds were found to be normal on clinical examination for parameters such as body 132 
condition, general appearance, heart and respiratory rate, palpation of abdominal organs and 133 
appearance of choanal and cloacal mucous membranes.  134 
From 2004 to 2007, a total of 144 plasma samples from 54 individuals were tested for APV-135 
specific antibodies. Of these, 48.1% (26/54) of the birds were found to be positive on at least one 136 
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sampling occasion in the BELISA, whereas 51.9% (28/54) always tested negative. Out of 36 137 
Spix’s macaws that were tested again in subsequent years for APV, 91.7% (33/36) displayed a 138 
consistent APV-BELISA result, with 18 birds showing consistently positive and 15 showing 139 
consistently negative results (Table. 1). Only three birds showed changing APV-BELISA results 140 
in the study period: two had initial positive results followed by a gradual decline to negative 141 
results, and one showed high percentages of inhibition (positive results) in three tests interspersed 142 
with one negative result (0% inhibition).  143 
A closer examination of the BELISA percentages of inhibition revealed some fluctuations 144 
for each individual over the time period; however, they remained well above 70% in all of the 145 
consistently seropositive birds. The mean percentage of inhibition (with 95% CI) of the APV-146 
BELISA positive subpopulation ranged from 86.8% (82.2% - 91.4%, n=13) in 2005, to 98.8% 147 
(98.2% - 99.7%, n=16) in 2007. In case of the APV-BELISA negative birds, mean percentage of 148 
inhibition remained consistently between 16.7% (9.5% – 23.9%, n=10) to 13.3% (9.4% – 17.3%, 149 
n=14) in 2004 and 2006, respectively.  To date all AWWP hatched and hand-reared chicks tested 150 
(n=10), have always shown negative APV-BELISA results in repeated samples. However, this 151 
was not the case with juveniles imported from Switzerland or the Philippines, with the youngest 152 
bird showing a positive APV_BELISA result at the age of one year (Table1; Bird Number 35). In 153 
addition, investigation into the origin of all APV-antibody positive birds indicated that, with the 154 
exception of one bird of Swiss origin, all seropositive birds originated from the Philippines.  155 
Between 2004 and 2006, whole blood and/or feather samples were also tested for the 156 
presence of APV DNA using PCR. In total, 81 samples (69 only blood; 11 combined blood and 157 
feather; 1 only feather) from 44 birds were tested over the period of three years. Of these, 2.3% 158 
(1/44) birds tested positive for APV specific DNA in whole blood samples. All feather samples 159 
DEB ET AL.- APV-ANTIBODIES IN SPIX’S MACAWS 8 
were negative. A comparison of results of PCR testing with APV-BELISA results of individual 160 
birds revealed that PCR-positive bird (Bird number 31) tested negative in BELISA (Table 1). 161 
A summary of mean, standard deviation (SD), range of hematologic values and AST is 162 
shown in Table 2. No statistically significant differences were found between APV-BELISA 163 
positive and negative juvenile birds for white blood cell count, percentage of lymphocytes, 164 
percentage of monocytes, or AST (data not shown). However, statistically significant differences 165 
were found between APV-BELISA positive and negative adult birds: white blood cell count (p = 166 
0.02) was higher in positively tested birds as compared to negatively tested birds, and AST 167 
concentration (p = 0.014) was higher in APV negatively tested birds as compared to positively 168 
tested birds.  169 
 170 
DISCUSSION 171 
The purpose of this study was to perform a retrospective evaluation of data recording clinical 172 
health status, APV-specific antibody titers, and PCR results for APV-DNA in a closed captive 173 
population of unvaccinated adult Spix’s macaws over a period of 4 years. The results should 174 
contribute to the understanding of the nature and course of natural APV infection within this 175 
population at AWWP and, possibly, to augment recent efforts in determining the duration of 176 
persistence of antibodies following naturally acquired APV infections in macaw species. 177 
Attempts have been made to characterize the persistence of antibodies and the duration of 178 
cloacal virus shedding for APV in a number of psittacine species; the variation observed has been 179 
attributed to the species, age at the time of exposure, concurrent infections like psittacine beak 180 
and feather disease (PBFD),and certain unidentified individual factors.5,6,8,9,14,19 The susceptibility 181 
of macaws to APV infections has been previously noted5,9,13,21,37 and this study presents evidence 182 
that the Spix’s macaw is no exception. As a majority of the birds that tested positive were 183 
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acquired as adults, the age of exposure or history of clinical illness cannot be elucidated. Notably, 184 
PBFD has never been detected during routine annual testing for the virus since 2004. In addition, 185 
this study confirms the conclusion of several authors that antibodies to APV can be detected in 186 
adult non-budgerigar psittacine birds in the absence of clinical symptoms.8,13,19,21,31,38  187 
In case of budgerigars, antibody titers are sustained for periods of up to 5 years- presumed to 188 
be life-long, and viral shedding from the cloaca ceases at the onset of sexual maturity.13,15,17,21,39 189 
Recent investigations have contributed to the hitherto scarce data on the course of infection in 190 
non-budgerigar psittacines. In macaws, the susceptibility to potentially fatal clinical disease is 191 
pronounced between 4-14 weeks of age; thereafter exposure leads to inapparent infection.5,6,13 192 
Initial serosurveys in non-budgerigar psittacines suggested that antibody titers are transient 193 
following APV infection and decline within weeks of infection.6,9 Subsequent research has 194 
demonstrated that antibodies can persist for up to 2 years; that viraemia, when present, is always 195 
detected and does not necessarily correlate with antibody status. Also, cloacal shedding of virus 196 
can occur irregularly for up to a year.8,14 197 
Our retrospective analysis of testing results for APV-specific antibodies in the Spix’s macaw 198 
population at AWWP revealed that most of the birds showed consistently positive or negative 199 
results over the period of four years when sampled repeatedly. Only three birds demonstrated an 200 
observable changing pattern of results, of which two had declining antibody levels. In case of the 201 
third bird, a deterioration of one sample during storage or shipment provides a likely explanation 202 
for the result of 0% inhibition at one time-point and three strong positive results at the remaining 203 
time-points of analysis. 204 
In general, the extremely low detection rate of the APV genome suggests that the isolated 205 
positive PCR result was a result of contamination either at the time of sampling or at the 206 
laboratory. This is supported by our observation that three pairs comprising one APV-antibody 207 
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positive and one negative bird were housed together with no change in antibody status during the 208 
period of four years, indicating that virus transmission did not occur. This drawback of the 209 
extremely high sensitivity of the PCR has been previously acknowledged.8 Although viraemia 210 
cannot be completely ruled out, it is highly unlikely given that the bird (Bird number 31) was a 211 
young hand-reared bird that had not been exposed to the adult population, compounded by the 212 
fact that the bird was seronegative at the time of sampling and did not seroconvert in subsequent 213 
tests (Table 1). In this case sequencing of the PCR products would have been invaluable in order 214 
to arrive at a conclusion, however, the retrospective nature of this study denied the authors this 215 
possibility.  216 
Blood and serum biochemistry parameters for APV-infected birds have only been described 217 
for non-budgerigar psittacines with active and fatal infections.8,37 In our study, significantly 218 
higher total WBC counts were found in the APV antibody positive adult birds, as compared to 219 
seronegative birds. The distinct reasons for this finding are not known; nevertheless, it could be 220 
speculated that it reflects a stimulation of the immune system by APV infection. In apparently 221 
healthy budgerigars, APV had a higher detection rate in tissues as compared to serum17, and the 222 
possibility that the virus persists in other tissues of the Spix’s macaws, as well, will remain a 223 
hypothesis that cannot be substantiated at this point. The finding of lower AST levels in APV 224 
antibody positive birds as compared to negative birds is in marked contrast to previously reported 225 
studies.8 However, these studies were performed on acutely diseased birds and despite the 226 
statistical significance recorded here, the probability of it being an unrelated incidental finding is 227 
high.  228 
The Spix’s macaw population at AWWP plays a significant role in the international species 229 
recovery and rehabilitation program. As determined in this study, the likelihood of virus 230 
transmission within the adult population is low. However, in future PCR screening of cloacal 231 
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swabs from these birds would be an essential step in bridging the gap necessary to gauge the 232 
potential risk for infection of Spix’s macaw chicks, since it has been demonstrated that cloacal 233 
shedding can continue after viraemia caeses in macaws.8,14,40 234 
At present all eggs from Spix’s macaws are pulled from the nest and chicks hand-reared 235 
before introduction to the breeding population. There remains a possibility that some of the adult 236 
birds might be shedding the virus. In the absence of this data, however, precautions to ensure that 237 
the chicks are not exposed to the breeding population between 4 to 14 weeks should be adequate 238 
to protect them against clinical APV disease. In conclusion, this study demonstrates the 239 
persistence of antibodies to APV for up to four years in Spix’s macaws, with little evidence of 240 
viraemia or virus transmission between seropositive and seronegative birds, thereby indicating a 241 
low level of risk for the hand-reared juvenile Spix’s macaw- a valuable conservation resource.   242 
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TABLE 1. Summary of serological results using the BELISA of 36 Spix’s macaws tested 344 
repeatedly for APV-specific antibodies between 2004 and 2007. The percentage of inhibition is 345 
shown; percentages >50% are considered positive, percentages <50% are considered negative. 346 
Positive results are highlighted by shading the cell. APV-PCR positive results are indicated with 347 
(*). The cage mate at the time of testing, where available, is indicated in superscript and 348 
corresponds to the “Bird Number” column (eg. bird number 7 was housed with bird number 28 349 




2004 2005 2006 2006(retest) 2007 
Persistent BELISA-Positive Results (n=18) 
1 89%4 85%4     100%4 
2 89%36 73%36 96%36   100%29 
3 95%5 79%5     100%5 
4 98% 90%1     100%1 
5 95%3 89%3     100%3 
6 95% 88%       
7 90%28   100%29 90%29   
8 95% 97%15     100%15 
9 90%10 96%10 100%10 90%10 100%14  
10 87%9 94%9 100%9 89%9 100%27 
11       100% 100% 
12 93%       99%13 
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13 92%14       100%12 
14 94%13   100%18   99%9 
15   90%8     100%8 
16 95%34 76%34 97%34   88%34 
17 88% 83% 100%32 90%32 100%32   
18   90%14 100%14   97% 
Persistent BELISA-Negative Results (n=15) 
 
19   13% 20%     
20 1%21   16%28 16%28   
21 15%20   11%25 13%25 47%25  
22 16%23   13%23     
23 21%22   24%22     
24 16%26 23%26       
25 20%27   15%21 22%21 16%21 
26 19%24 15%24 11%   0% 
27 26%25 26%25 13%   0%10 
28 1%7   21%20    
29 33%   19%7   0%2 
30   19% 13%   0%31 
31     12%(*) 14%30 0%30 
32   0% 1%17     
33   16% 0%     
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Changing Results (n=3) 
34 67%16 50%16 23%16   9%16 
35   78% 36% 26% 14% 
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TABLE 2.  356 
Mean, standard deviation (SD) and range of haematologic values as well as AST concentration 357 
for adult Spix’s macaws (Cyanopsitta spixii) with regard to positive or negative result in APV-358 
BELISA testing from 2004-2006.  359 
Note: a,b: differences between means are significant (p =  0.02), c,d: differences between means 360 
are significant (p =  0.014). 361 
 362 
Parameter 
Positive APV titre 
[mean ± SD and range] 
n = 53 
Negative APV titre 
[mean ± SD and range] 
n = 36 
 
White blood cells (x 103/µl) 
 
10.8 ± 4.4 [3-25] a 
 
8.6 ± 4 [2.8-17.2] b 
Heterophils (%) 59.9 ± 15.9 [26-83] 61.7 ± 13.2 [32-85] 
Lymphocytes (%) 37 ± 16.5 [8-73] 35.2 ± 13.1 [14-67] 
Monocytes (%) 3.2 ± 2.6 [1-12] 3.5 ± 2.4 [1-13] 
AST (U/l) 136 ± 49.9 [21-364] c 172.9 ± 77.1 [82.8-471] d 
 363 
 364 
